Clinical trial Recruiting at 3 sites Interventional Ages 18 and up

Mobile app for alcohol cessation in liver disease patients

Official title: Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease (IMPACT-ALD): Aim 1

Run by University of Wisconsin, Madison · NCT06305624 · Data updated 2026-11-12

This study is testing whether a smartphone app can help people with alcohol-related liver disease stop drinking more effectively than just regular care alone.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment298 (estimated)
SponsorUniversity of Wisconsin, Madison
Academic / other
Locations3 sites (Lansing, Michigan and 2 other locations)
StatusRecruiting
StartedJune 1, 2024
Main results expectedOctober 31, 2027
Study endsOctober 31, 2027
Registry record updatedJuly 31, 2026
Trial IDNCT06305624 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals diagnosed with any stage of alcohol-associated liver disease who have consumed alcohol in the last 6 months and are receiving care at the participating medical centers.

Probably not a fit

Patients who are actively listed for liver transplant, in hospice care, or have severe cognitive impairment may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of the CHESS Health Connections smartphone application in helping patients with alcohol-associated liver disease (ALD) achieve alcohol cessation. Conducted at two major medical centers in Michigan and Wisconsin, the trial will enroll 298 participants who will be monitored for up to 6 months. The study compares the outcomes of patients using the app alongside usual care to those receiving only usual care, aiming to improve abstinence rates and liver function. Additionally, qualitative interviews will assess the implementation of the app within clinical settings.

Why it matters

Potential benefit: If successful, this approach could significantly enhance alcohol cessation rates and improve liver health in patients with alcohol-associated liver disease.

How similar studies have gone: Previous studies have shown promise in using mobile health applications for alcohol cessation, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria (Aim 1):

* Diagnosis of ALD (any stage)
* Alcoholic liver disease (ALD) encompasses a spectrum of hepatic injuries caused by long-term alcohol abuse. For this study, participants will have a diagnosis of ALD or evidence of the combination of liver disease and alcohol misuse in electronic health record.
* Alcohol use within the last 6 months
* Receiving care at UW or Henry Ford Health + MSU

  * Either the general hepatology clinic or the multidisciplinary ALD clinic
* Able to read and write proficiently in English
* Willing and able to use a smartphone app

Exclusion Criteria:

* Actively listed for liver transplant or history of liver transplant before being enrolled in the study. Participants added to a liver transplant list after being enrolled in the study will be allowed to continue their participation
* In hospice care
* Has severe cognitive impairment (as described in electronic health record including dementia, delirium, and/or unable to maintain cognitive alertness during screening--as determined by study staff.)

Where it's running

  • Henry Ford + Michigan State University Health Center
    Lansing, Michigan, United States
    Recruiting
  • UW General Hepatology Clinic
    Madison, Wisconsin, United States
    Recruiting
  • UW Multidisciplinary ALD Clinic
    Madison, Wisconsin, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.